Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
566K
-
Shares change
-
+141K
-
Total reported value, excl. options
-
$990K
-
Value change
-
+$232K
-
Number of buys
-
4
-
Number of sells
-
-3
-
Price
-
$1.74
Significant Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q3 2018
10 filings reported holding ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock as of Q3 2018.
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 566K shares
of 129M outstanding shares and own 0.44% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (465K shares), Vanguard Group Inc (33.9K shares), JANE STREET GROUP, LLC (23.6K shares), GEODE CAPITAL MANAGEMENT, LLC (15.8K shares), Virtu Financial LLC (13.8K shares), PANAGORA ASSET MANAGEMENT INC (13.6K shares), BlackRock Inc. (617 shares), UBS Group AG (0 shares), DEUTSCHE BANK AG\ (0 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.